Ocular Surface and Tear Cytokine Changes after Cataract Surgery in Patients with Type 2 Diabetes

References

• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843.
   PubMed Web of Science ®Google Scholar
• Tomkins-Netzer O, Ismetova F, Bar A, et al. Functional outcome of macular edema in different retinal disorders. Prog Retin Eye Res. 2015;48:119–136. doi:10.1016/j.preteyeres.2015.05.002.
   PubMed Web of Science ®Google Scholar
• Richdale K, Chao C, Hamilton M. Eye care providers’ emerging roles in early detection of diabetes and management of diabetic changes to the ocular surface: a review. BMJ Open Diabetes Res Care. 2020;8:1. doi:10.1136/bmjdrc-2019-001094.
   Web of Science ®Google Scholar
• He F, Zhao Z, Liu Y, et al. Assessment of ocular surface damage during the course of type 2 diabetes mellitus. J Ophthalmol. 2018;2018:1206808. doi:10.1155/2018/1206808.
   PubMed Web of Science ®Google Scholar
• Kyung-Chul Yoon M, Seong-Kyu Im MD, Man-Seong Seo MD. Changes of tear film and ocular surface in diabetes mellitus. Korean J Ophthalmol. 2004;18:168–174. doi:10.3341/kjo.2004.18.2.168.
   PubMedGoogle Scholar
• Lin X, Xu B, Zheng Y, et al. Meibomian gland dysfunction in type 2 diabetic patients. J Ophthalmol. 2017;2017:3047867. doi:10.1155/2017/3047867.
   PubMed Web of Science ®Google Scholar
• Yu T, Shi WY, Song AP, et al. Changes of meibomian glands in patients with type 2 diabetes mellitus. Int J Ophthalmol. 2016;9(12):1740–1744. doi:10.18240/ijo.2016.12.06.
   PubMed Web of Science ®Google Scholar
• Sandra Johanna GP, Antonio LA, Andrés GS. Correlation between type 2 diabetes, dry eye and Meibomian glands dysfunction. J Optom. 2019;12(4):256–262. doi:10.1016/j.optom.2019.02.003.
   PubMedGoogle Scholar
• Baek J, Doh SH, Chung SK. Assessment of the tear meniscus using optical coherence tomography in patients with type 2 diabetes mellitus. Cornea. 2015;34(12):1534–1540. doi:10.1097/ICO.0000000000000651.
   PubMed Web of Science ®Google Scholar
• Beckman KA. Characterization of dry eye disease in diabetic patients versus nondiabetic patients. Cornea. 2014;33(8):851–854. doi:10.1097/ICO.0000000000000163.
   PubMed Web of Science ®Google Scholar
• Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology. 2001;108(3):586–592. doi:10.1016/S0161-6420(00)00599-6.
   PubMed Web of Science ®Google Scholar
• Viso E, Rodríguez-Ares MT, Abelenda D, et al. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci. 2012;53(6):2601–2606. doi:10.1167/iovs.11-9228.
   PubMed Web of Science ®Google Scholar
• DeMill DL, Hussain M, Pop-Busui R, Shtein RM. Ocular surface disease in patients with diabetic peripheral neuropathy. Br J Ophthalmol. 2016;100(7):924–928. doi:10.1136/bjophthalmol-2015-307369.
   PubMed Web of Science ®Google Scholar
• Edwards K, Pritchard N, Vagenas D, et al. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin Exp Optom. 2012;95(3):348–354. doi:10.1111/j.1444-0938.2012.00740.x.
   PubMed Web of Science ®Google Scholar
• Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067–2072. doi:10.1161/01.CIR.0000034509.14906.AE.
   PubMed Web of Science ®Google Scholar
• Liu J, Shi B, He S, et al. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol Vis. 2010;16:2931–2938.
   PubMed Web of Science ®Google Scholar
• Costagliola C, Romano V, De Tollis M, et al. TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm. 2013;2013:629529. doi:10.1155/2013/629529.
   PubMed Web of Science ®Google Scholar
• Cetinkaya S, Mestan E, Acir NO, et al. The course of dry eye after phacoemulsification surgery. BMC Ophthalmol. 2015;15:68. doi:10.1186/s12886-015-0058-3.
   PubMed Web of Science ®Google Scholar
• Kim J, Chung J, Kang S, et al. Change in corneal sensitivity and corneal nerve after cataract surgery. Cornea. 2009;28(Suppl. 1):S20–S5. doi:10.1097/ICO.0b013e3181aea0e3.
   Google Scholar
• Li XM, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea. 2007;26(9 Suppl 1):S16–20. doi:10.1097/ICO.0b013e31812f67ca.
   PubMed Web of Science ®Google Scholar
• Han KE, Yoon SC, Ahn JM, et al. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery. Am J Ophthalmol. 2014;157(6):1144–50 e1. doi:10.1016/j.ajo.2014.02.036.
   PubMed Web of Science ®Google Scholar
• Cho YK, Kim MS. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol. 2009;23(2):65–73. doi:10.3341/kjo.2009.23.2.65.
   PubMedGoogle Scholar
• Park Y, Hwang HB, Kim HS, Wedrich A. Observation of influence of cataract surgery on the ocular surface. PLoS One. 2016;11(10):e0152460. doi:10.1371/journal.pone.0152460.
   PubMed Web of Science ®Google Scholar
• Jee D, Park M, Lee HJ, et al. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome. J Cataract Refract Surg. 2015;41(4):756–763. doi:10.1016/j.jcrs.2014.11.034.
   PubMed Web of Science ®Google Scholar
• Jung JW, Han SJ, Nam SM, et al. Meibomian gland dysfunction and tear cytokines after cataract surgery according to preoperative meibomian gland status. Clin Exp Ophthalmol. 2016;44(7):555–562. doi:10.1111/ceo.12744.
   PubMed Web of Science ®Google Scholar
• Liu X, Gu YS, Xu YS. Changes of tear film and tear secretion after phacoemulsification in diabetic patients. J Zhejiang Univ Sci B. 2008;9(4):324–328. doi:10.1631/jzus.B0710359.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang S, Yu J, et al. Changes of the tear film lipid layer thickness after cataract surgery in patients with diabetes mellitus. Acta Ophthalmol. 2021;99(2):e202–e8. doi:10.1111/aos.14565.
   PubMed Web of Science ®Google Scholar
• Jiang D, Xiao X, Fu T, et al. Transient tear film dysfunction after cataract surgery in diabetic patients. Plos One. 2016;11(1):e0146752. doi:10.1371/journal.pone.0146752.
   PubMed Web of Science ®Google Scholar
• Chylack LT Jr., Wolfe JK, Singer DM, et al. The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol. 1993;111(6):831–836. doi:10.1001/archopht.1993.01090060119035.
   PubMedGoogle Scholar
• Kabosova A, Kramerov AA, Aoki AM, et al. Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture. Exp Eye Res. 2003;77(2):211–217. doi:10.1016/S0014-4835(03)00111-8.
   PubMed Web of Science ®Google Scholar
• Zagon IS, Sassani JW, McLaughlin PJ. Insulin treatment ameliorates impaired corneal reepithelialization in diabetic rats. Diabetes. 2006;55(4):1141–1147. doi:10.2337/diabetes.55.04.06.db05-1581.
   PubMed Web of Science ®Google Scholar
• Wakuta M, Morishige N, Chikama T, et al. Delayed wound closure and phenotypic changes in corneal epithelium of the spontaneously diabetic Goto-Kakizaki rat. Invest Ophthalmol Vis Sci. 2007;48(2):590–596. doi:10.1167/iovs.05-1168.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. Plos One. 2009;4(12):e8158. doi:10.1371/journal.pone.0008158.
   PubMed Web of Science ®Google Scholar
• Dong N, Xu B, Chu L, Tang X. Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema. Plos One. 2015;10(4):e0125329. doi:10.1371/journal.pone.0125329.
   PubMed Web of Science ®Google Scholar
• Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol. 2008;8:10. doi:10.1186/1471-2415-8-10.
   PubMed Web of Science ®Google Scholar
• Ozdemir M, Buyukbese MA, Cetinkaya A, Ozdemir G. Risk factors for ocular surface disorders in patients with diabetes mellitus. Diabetes Res Clin Pract. 2003;59(3):195–199. doi:10.1016/S0168-8227(02)00244-9.
   PubMed Web of Science ®Google Scholar
• Panigrahi T, Shivakumar S, Shetty R, et al. Trehalose augments autophagy to mitigate stress induced inflammation in human corneal cells. Ocul Surf. 2019;17(4):699–713. doi:10.1016/j.jtos.2019.08.004.
   PubMed Web of Science ®Google Scholar
• Shamloo K, Mistry P, Barbarino A, et al. Differential effect of proinflammatory cytokines on corneal and conjunctival epithelial cell mucins and glycocalyx. Transl Vis Sci Technol. 2021;10(7):17. doi:10.1167/tvst.10.7.17.
   PubMed Web of Science ®Google Scholar
• Chen YT, Nikulina K, Lazarev S, et al. Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren’s syndrome. Am J Pathol. 2010;177(3):1333–1343. doi:10.2353/ajpath.2010.100227.
   PubMed Web of Science ®Google Scholar
• De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci. 2007;48(6):2553–2560. doi:10.1167/iovs.07-0069.
   PubMed Web of Science ®Google Scholar
• Gamache DA, Dimitrijevich SD, Weimer LK, et al. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm. 1997;5(2):117–128. doi:10.3109/09273949709085060.
   PubMed Web of Science ®Google Scholar
• Na KS, Mok JW, Kim JY, et al. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012;53(9):5443–5450. doi:10.1167/iovs.11-9417.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Al-Kharashi SA, et al. Chemokines in the limbal form of vernal keratoconjunctivitis. Br J Ophthalmol. 2000;84(12):1360–1366. doi:10.1136/bjo.84.12.1360.
   PubMed Web of Science ®Google Scholar
• Sun YC, Tang YH, Liou HM, et al. Tear cytokine profiling in patients with superior limbic keratoconjunctivitis who underwent medical treatment or in conjunction with surgical management. Br J Ophthalmol. 2020;104(5):735–740. doi:10.1136/bjophthalmol-2018-313358.
   PubMed Web of Science ®Google Scholar
• Tominaga T, Miyazaki D, Sasaki S, et al. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2. Invest Ophthalmol Vis Sci. 2009;50(11):5181–5188. doi:10.1167/iovs.09-3637.
   PubMed Web of Science ®Google Scholar
• Tuaillon N, Shen DF, Berger RB, et al. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2002;43(5):1493–1498.
   PubMed Web of Science ®Google Scholar
• Kim JS, Chung SH, Joo CK. Clinical application of a Scheimpflug system for lens density measurements in phacoemulsification. J Cataract Refract Surg. 2009;35(7):1204–1209. doi:10.1016/j.jcrs.2009.02.032.
   PubMed Web of Science ®Google Scholar